Your browser doesn't support javascript.
loading
Establishing Rationale for the Clinical Development of Cell Therapy Products: Consensus between Risk and Benefit.
Han, Seunghoon; Yim, Hyeon Woo; Jeong, Hyunsuk; Choi, Suein; Han, Sungpil.
Affiliation
  • Han S; Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Yim HW; Department of Clinical Pharmacology and Therapeutics, The Catholic University of Korea Seoul St. Mary's Hospital, Seoul, Korea.
  • Jeong H; Department of Preventive Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Choi S; Department of Preventive Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Han S; Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Int J Stem Cells ; 16(1): 16-26, 2023 Feb 28.
Article in En | MEDLINE | ID: mdl-36581365
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: Int J Stem Cells Year: 2023 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: Int J Stem Cells Year: 2023 Document type: Article Country of publication: